R&D Changing Faces: Pharma and biotech, April 2026 April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.
R&D Changing Faces: Board of Directors and Advisory Boards, Marc... Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, March 202... March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.
Digital Changing Faces: Digital and supplier, March 2026 Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.
R&D Changing Faces: Pharma and biotech, March 2026 A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.
R&D Changing Faces: Board of Directors and Advisory Boards, Febr... Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.
News Ex-BioNTech execs launch 'AI-native' cancer company Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
